VC
GSK icon

Voit & Company’s GSK GSK Stock Holding History

Voit & Company’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-6,916
Closed -$328K – 54
2020
Q1 		$328K Buy
6,916
+904
+15% +$48.2K 0.34% 53
2019
Q4 		$353K Hold
6,012
– – 0.31% 51
2019
Q3 		$321K Sell
6,012
-80
-1% -$4.12K 0.32% 50
2019
Q2 		$305K Sell
6,092
-320
-5% -$16.1K 0.29% 54
2019
Q1 		$335K Buy
6,412
+1,760
+38% +$87.9K 0.35% 50
2018
Q4 		$222K Buy
+4,652
New +$229K 0.28% 56

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Voit & Company's GSK Position: Q2 2020 in Review

Voit & Company sold out of GSK (GSK) in Q2 2020, closing a stake of 6,916 shares — an estimated $328K sold.

Voit & Company first reported a position in GSK in Q4 2018 and held it in 6 quarters. The position peaked at $353K in Q4 2019. 841 funds tracked by Wall St. Rank hold GSK as of Q2 2020.

  • Voit & Company reported no remaining GSK position as of Q2 2020 after selling out during the quarter.
  • Voit & Company sold 6,916 GSK shares in Q2 2020, an estimated $328K.
  • Voit & Company first reported a position in GSK in Q4 2018 and held it in 6 quarters.
  • Voit & Company's GSK position peaked at $353K in Q4 2019.
  • 841 funds tracked by Wall St. Rank held GSK as of Q2 2020.

Based on Voit & Company's 13F filing for Q2 2020, filed 31 Jul 2020.